Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes

L. Engelen, S.S. Lund, I. Ferreira, L. Tarnow, H.H. Parving, J. Gram, K. Winther, O. Pedersen, T. Teerlink, R. Barto, C.D.A. Stehouwer, A.A. Vaag, C.G. Schalkwijk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)371-379
JournalEuropean Journal of Endocrinology
Issue number3
Publication statusPublished - 2011

Cite this